But compressing timetables is also pushing the limits of drug manufacturing capabilities. This is particularly true for biologic agents ... with a production workflow based on modular pods ...

and energy requirements by 50% One of the underappreciated challenges of the biologics manufacturing workflow is the fill-finish step. This describes the last mile of production, when the drug is ...